XML 19 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue:      
Premium revenue $ 30,883 $ 26,855 $ 18,299
Premium tax revenue 873 787 649
Health insurer fees reimbursed 0 0 271
Marketplace risk corridor judgment 0 0 128
Investment income 143 52 59
Other revenue 75 77 17
Total revenue 31,974 27,771 19,423
Operating expenses:      
Medical care costs 27,175 23,704 15,820
General and administrative expenses 2,311 2,068 1,480
Premium tax expenses 873 787 649
Health insurer fees 0 0 277
Depreciation and amortization 176 131 88
Impairment 208 0 0
Other 58 61 31
Total operating expenses 30,801 26,751 18,345
Operating income 1,173 1,020 1,078
Other expenses, net:      
Interest expense 110 120 102
Other expenses, net 0 25 15
Total other expenses, net 110 145 117
Income before income tax expense 1,063 875 961
Income tax expense 271 216 288
Net income $ 792 $ 659 $ 673
Net income per share:      
Basic (in dollars per share) $ 13.72 $ 11.40 $ 11.40
Diluted (in dollars per share) $ 13.55 $ 11.25 $ 11.23
Weighted average shares outstanding:      
Basic (in shares) 57.8 57.8 59.0
Diluted (in shares) 58.5 58.6 59.9